BCNU
Term · Oncology and biomedicine · MLC-T-ONC-000955
A drug used alone or with other drugs to treat certain types of brain tumors, Hodgkin lymphoma, and non-Hodgkin lymphoma and with prednisone to treat multiple myeloma. It is also being studied in the treatment of other types of cancer. BCNU damages the cell's DNA and may kill cancer cells. It is a type of alkylating agent and a type of nitrosourea. Also called BiCNU and carmustine.
| Identifier | MLC-T-ONC-000955 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | carmustine |
| Synonyms | BiCNU |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-000955",
"term": "BCNU",
"field": "Oncology and biomedicine",
"definition": "A drug used alone or with other drugs to treat certain types of brain tumors, Hodgkin lymphoma, and non-Hodgkin lymphoma and with prednisone to treat multiple myeloma. It is also being studied in the treatment of other types of cancer. BCNU damages the cell's DNA and may kill cancer cells. It is a type of alkylating agent and a type of nitrosourea. Also called BiCNU and carmustine.",
"expansions": [
"carmustine"
],
"synonyms": [
"BiCNU"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/bcnu/"
}
Record 3,362 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.